asa statement glp-1 Anesthetic Considerations for Patients Taking Glucagon-Like Peptide-1 Agonists Glucagon-Like Peptide-1 Agonists and General

5: L-carnitine, biotin, panthenol, bisabolol, and -tocopherol

Making lasting lifestyle changes : Building healthy habits around food and movement during treatmentand sticking with them afterwardcan help prevent the weight from creeping back

NICE recommends using fracture risk assessment tools such as FRAX (Fracture Risk Assessment Tool) or QFracture to identify patients who would benefit from DEXA scanning

Compared with other CVOTs involving GLP-1RA, participants in the AMPLITUDE-O trial had the longest duration of diabetes (15 years), lowest mean eGFR (72 ml/min/1.73 m 2 ) with a higher percentage (32%) of people with renal disease (eGFR 2560 mL/min), highest glycosilated hemoglobin (8.9%), and highest percentage of insulin use (62%) or sodiumglucose transporter-2 inhibitors (SGLT-2i) (15%) at baseline, thus identifying a more fragile population